Xycrobe Therapeutics
2014
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
3
FINANCING ROUNDS
Description
Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to address the needs of patients with inflammatory skin disease.
Primary Industry
Biotechnology
Acquirer
Primary Office
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Xycrobe Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Xycrobe Therapeutics‘s full profile, request access.
Request full access to PitchBookXycrobe Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Xycrobe Therapeutics‘s full profile, request access.
Request full access to PitchBook